GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 797 filers reported holding GLAXOSMITHKLINE PLC in Q2 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $294,000 | +0.7% | 6,744 | +0.5% | 0.04% | +15.4% |
Q1 2022 | $292,000 | -0.7% | 6,712 | +0.7% | 0.04% | 0.0% |
Q4 2021 | $294,000 | +17.6% | 6,667 | +4.3% | 0.04% | +14.7% |
Q3 2021 | $250,000 | -1.2% | 6,390 | +0.7% | 0.03% | -2.9% |
Q2 2021 | $253,000 | -1.9% | 6,348 | -12.1% | 0.04% | -7.9% |
Q1 2021 | $258,000 | -8.5% | 7,221 | -5.7% | 0.04% | -22.4% |
Q4 2020 | $282,000 | – | 7,661 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JTC Employer Solutions Trustee Ltd | 5,993,336 | $264,217,000 | 32.64% |
Black Creek Investment Management Inc. | 10,373,943 | $457,491,000 | 12.20% |
KAHN BROTHERS GROUP INC | 1,438,569 | $63,440,893,000 | 8.71% |
EQUITY INVESTMENT CORP | 2,932,078 | $129,305,000 | 4.68% |
JET CAPITAL INVESTORS L P | 400,000 | $17,640,000 | 4.67% |
Eversept Partners, LP | 1,503,700 | $66,313,170 | 4.24% |
NKCFO LLC | 269,500 | $11,885,000 | 3.82% |
Camber Capital Management LP | 2,500,000 | $110,250,000 | 3.79% |
CLIFFORD CAPITAL PARTNERS LLC | 113,866 | $5,021,000 | 3.75% |
Robinson Value Management, Ltd. | 97,677 | $4,308,000 | 3.54% |